65 related articles for article (PubMed ID: 11832770)
1. Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells.
Liu Z; Hopkins MM; Zhang Z; Quisenberry CB; Fix LC; Galvan BM; Meier KE
J Pharmacol Exp Ther; 2015 Feb; 352(2):380-94. PubMed ID: 25491146
[TBL] [Abstract][Full Text] [Related]
2. Activation of GPR56, a novel adhesion GPCR, is necessary for nuclear androgen receptor signaling in prostate cells.
Singh JP; Dagar M; Dagar G; Kumar S; Rawal S; Sharma RD; Tyagi RK; Bagchi G
PLoS One; 2020; 15(9):e0226056. PubMed ID: 32881870
[TBL] [Abstract][Full Text] [Related]
3. Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles.
Mohammadinejad R; Moosavi MA; Tavakol S; Vardar DÖ; Hosseini A; Rahmati M; Dini L; Hussain S; Mandegary A; Klionsky DJ
Autophagy; 2019 Jan; 15(1):4-33. PubMed ID: 30160607
[TBL] [Abstract][Full Text] [Related]
4. A Testosterone Metabolite 19-Hydroxyandrostenedione Induces Neuroendocrine Trans-Differentiation of Prostate Cancer Cells
Abaffy T; Bain JR; Muehlbauer MJ; Spasojevic I; Lodha S; Bruguera E; O'Neal SK; Kim SY; Matsunami H
Front Oncol; 2018; 8():162. PubMed ID: 29892571
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting G protein βγ signaling blocks prostate cancer progression and enhances the efficacy of paclitaxel.
Paudyal P; Xie Q; Vaddi PK; Henry MD; Chen S
Oncotarget; 2017 May; 8(22):36067-36081. PubMed ID: 28415604
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia.
Nomura T; Yamasaki M; Hirai K; Inoue T; Sato R; Matsuura K; Moriyama M; Sato F; Mimata H
Mol Cancer; 2013 Apr; 12():27. PubMed ID: 23566222
[TBL] [Abstract][Full Text] [Related]
7. Caveolae contribute to the apoptosis resistance induced by the alpha(1A)-adrenoceptor in androgen-independent prostate cancer cells.
Katsogiannou M; El Boustany C; Gackiere F; Delcourt P; Athias A; Mariot P; Dewailly E; Jouy N; Lamaze C; Bidaux G; Mauroy B; Prevarskaya N; Slomianny C
PLoS One; 2009 Sep; 4(9):e7068. PubMed ID: 19763272
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as novel anticancer agents: synthesis, biological evaluation, and structure-activity relationships.
Lu Y; Li CM; Wang Z; Ross CR; Chen J; Dalton JT; Li W; Miller DD
J Med Chem; 2009 Mar; 52(6):1701-11. PubMed ID: 19243174
[TBL] [Abstract][Full Text] [Related]
9. Kinin b2 receptor mediates induction of cyclooxygenase-2 and is overexpressed in head and neck squamous cell carcinomas.
Zhang W; Bhola N; Kalyankrishna S; Gooding W; Hunt J; Seethala R; Grandis JR; Siegfried JM
Mol Cancer Res; 2008 Dec; 6(12):1946-56. PubMed ID: 19074839
[TBL] [Abstract][Full Text] [Related]
10. A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells.
Bektas M; Payne SG; Liu H; Goparaju S; Milstien S; Spiegel S
J Cell Biol; 2005 Jun; 169(5):801-11. PubMed ID: 15939762
[TBL] [Abstract][Full Text] [Related]
11. Mitogen Activated Protein kinase signal transduction pathways in the prostate.
Maroni PD; Koul S; Meacham RB; Koul HK
Cell Commun Signal; 2004 Jun; 2(1):5. PubMed ID: 15219238
[TBL] [Abstract][Full Text] [Related]
12. Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells.
Barki-Harrington L; Bookout AL; Wang G; Lamb ME; Leeb-Lundberg LM; Daaka Y
Biochem J; 2003 Apr; 371(Pt 2):581-7. PubMed ID: 12534343
[TBL] [Abstract][Full Text] [Related]
13. Guanosine phosphate binding protein coupled receptors in prostate cancer: a review.
Raj GV; Barki-Harrington L; Kue PF; Daaka Y
J Urol; 2002 Mar; 167(3):1458-63. PubMed ID: 11832770
[TBL] [Abstract][Full Text] [Related]
14. Essential role for G proteins in prostate cancer cell growth and signaling.
Kue PF; Daaka Y
J Urol; 2000 Dec; 164(6):2162-7. PubMed ID: 11061948
[TBL] [Abstract][Full Text] [Related]
15. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
16. G proteins in cancer: the prostate cancer paradigm.
Daaka Y
Sci STKE; 2004 Jan; 2004(216):re2. PubMed ID: 14734786
[TBL] [Abstract][Full Text] [Related]
17. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C
Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626
[TBL] [Abstract][Full Text] [Related]
18. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.
Reddy GP; Barrack ER; Dou QP; Menon M; Pelley R; Sarkar FH; Sheng S
J Cell Biochem; 2006 Aug; 98(6):1408-23. PubMed ID: 16619263
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
